Muscular Atrophy

• 

  Subject Areas on Research

  • A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program. 
  • A model of muscle atrophy using cast immobilization in mice. 
  • A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding. 
  • Alterations in inorganic phosphate in mouse hindlimb muscles during limb disuse. 
  • Astrocytic proteins in the dorsal and ventral roots in amyotrophic lateral sclerosis and Werdnig-Hoffmann disease. 
  • Bedside ultrasound measurement of skeletal muscle. 
  • Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis. 
  • Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. 
  • Diabetic neuropathic cachexia and diabetic amyotrophy. 
  • Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction. 
  • Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury. 
  • Effects of spaceflight on murine skeletal muscle gene expression. 
  • G(s)alpha deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency. 
  • Hereditary motor and sensory neuropathy, X-linked: a half century follow-up. 
  • High-intensity strength training in nonagenarians. Effects on skeletal muscle. 
  • Histological Evidence of Muscle Degeneration in Advanced Human Rotator Cuff Disease. 
  • Innervation of the levator ani and coccygeus muscles of the female rat. 
  • Ipecac myopathy and cardiomyopathy. 
  • Midgestational sciatic nerve transection in fetal sheep results in absent nerve regeneration and neurogenic muscle atrophy. 
  • Muscle adaptations with immobilization and rehabilitation after ankle fracture. 
  • Muscle atrophy following nerve block therapy. 
  • Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. 
  • Muscle atrophy in transgenic mice expressing a human TSC1 transgene. 
  • Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse. 
  • Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. 
  • Palliative care pharmacotherapy literature summaries and analyses. 
  • Patellar tendon versus hamstring tendon autografts for anterior cruciate ligament reconstruction: a randomized controlled trial using similar femoral and tibial fixation methods. 
  • Postoperative atrophy of abdominal wall musculature: CT demonstration. 
  • Postoperative atrophy of posterolateral chest wall musculature: CT demonstration. 
  • Properties of medial gastrocnemius motor units and muscle fibers reinnervated by embryonic ventral spinal cord cells. 
  • Proximal muscle weakness and selenium deficiency associated with long term parenteral nutrition. 
  • Quantitative electromyography after poliomyelitis. 
  • Sarcopenia, weight loss, and nutritional frailty in the elderly. 
  • Simulation techniques in electromyography. 
  • Skeletal muscle loss: cachexia, sarcopenia, and inactivity. 
  • Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice. 
  • The posterior cricoarytenoid muscle is spared from MuRF1-mediated muscle atrophy in mice with acute lung injury. 
  • Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats.